Group 1 - The core viewpoint of the news is the strategic partnership between Huajian Medical and Renhe Pharmaceutical's subsidiary to establish the world's first OTC-focused RWA exchange in the U.S. [1] - This collaboration is a key step in Huajian Medical's "ETHK blockchain financial ecosystem strategy" and aims to create a replicable model to validate the feasibility and potential of this innovative approach [1][2] - Huajian Medical will provide compliance operational support through ETHK Inc, while Huajian Digital Industry Development (Shenzhen) Co., Ltd. will handle technology development [1] Group 2 - Renhe Pharmaceutical, a leading player in China's OTC market, aims to revitalize its brand and intangible assets through this partnership, especially after facing revenue declines of 16.46% and net profit drops of 13.87% in the first half of the year [1] - The collaboration is expected to generate significant technical service revenue for Huajian Medical and validate its light-asset, replicable empowerment model [2] - The "ETHK global RWA exchange" model is designed to connect the industry and financial sectors, providing asset selection, structural design, compliance issuance, and liquidity management services [2]